α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes ; volume:13 ; number:1 ; day:21 ; month:2 ; year:2024 ; pages:1-28 ; date:12.2024
Translational neurodegeneration ; 13, Heft 1 (21.2.2024), 1-28, 12.2024
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Leandrou, Emmanouela
Chalatsa, Ioanna
Anagnostou, Dimitrios
Machalia, Christina
Semitekolou, Maria
Filippa, Vicky
Makridakis, Manousos
Vlahou, Antonia
Anastasiadou, Ema
Vekrellis, Kostas
Emmanouilidou, Evangelia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40035-024-00401-4
- URN
-
urn:nbn:de:101:1-2404291313416.416166883849
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Leandrou, Emmanouela
- Chalatsa, Ioanna
- Anagnostou, Dimitrios
- Machalia, Christina
- Semitekolou, Maria
- Filippa, Vicky
- Makridakis, Manousos
- Vlahou, Antonia
- Anastasiadou, Ema
- Vekrellis, Kostas
- Emmanouilidou, Evangelia
- SpringerLink (Online service)
Ähnliche Objekte (12)
α-Synuclein oligomers form by secondary nucleation
Stabilization of α-synuclein oligomers using formaldehyde
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Structural characteristics and membrane interactions of tandem α-synuclein oligomers
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Neuroinflammatory astrocytes generated from cord blood-derived human induced pluripotent stem cells
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers
Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
Morphological Evaluation of Meta-stable Oligomers of α-Synuclein with Small-Angle Neutron Scattering
α-Synuclein oligomers form by secondary nucleation
Stabilization of α-synuclein oligomers using formaldehyde
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Structural characteristics and membrane interactions of tandem α-synuclein oligomers
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Neuroinflammatory astrocytes generated from cord blood-derived human induced pluripotent stem cells
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers
Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
Morphological Evaluation of Meta-stable Oligomers of α-Synuclein with Small-Angle Neutron Scattering
α-Synuclein oligomers form by secondary nucleation
Stabilization of α-synuclein oligomers using formaldehyde
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Optical Structural Analysis of Individual α‐Synuclein Oligomers
Structural characteristics and membrane interactions of tandem α-synuclein oligomers
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Neuroinflammatory astrocytes generated from cord blood-derived human induced pluripotent stem cells
Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers
Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties